Cobicistat Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since August 2026

Also known as: Tybost

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

Syndax Pharmaceuticals1
Stichting Hemato-Oncologie voor Volwassenen Nederland1

Indications

Cancer2
Mixed Lineage Acute Leukemia1
AML, Adult1
Mixed Phenotype Acute Leukemia1
Acute Leukemia of Ambiguous Lineage1

Other1 trial

A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML

Phase 2

Duarte, California1 trial

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

City of Hope Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.